Upholding this arbitrary decision… risks jeopardizing the viability of an industry intent on creating novel treatments for pediatric patients with sickle cell disease and other rare, severe genetic diseases.
Sen. Scott warns about consequences of FDA's decision.
Share & report
More from Tim Scott
America's global competitive edge is innovation and the American spirit to create.
Complete and timely attention to congressional inquiries is critical to ensuring independent agencies remain transparent and accountable to the American people.
Chair Gensler, as our economy and markets move forward, the SEC must keep moving forward and put American savers first.
Mr. President, in the first 48 hours following the October 7 Hamas terror attack on Israel, violent language and threats against the Jewish community and Israel increased by over 488 percent. This hatred is spreading like wildfire on…
Other voices in this conversation
